Government Shutdown Implications For the FDA
A government shutdown will severely restrict food and drug inspections. The FDA will not be able to conduct specific inspections of drug or medical device manufacturing facilities.
Articles by Herina Ayot
EDP Biotech Detects Early Stage Colon Cancer
Identification and detection of new biomarkers that identify the beginning stages of diseases is critical for achieving successful medical treatment. EDP Biotech Corporation is a […]
May 19, 2011 – May 20, 2011 The Burrill Latin America Life Sciences Conference
May 19, 2011 – May 20, 2011 SOFITEL RIO DE JANEIRO COPACABANA Rio de Janeiro, Brazil The Burrill Latin American Life Sciences Conference brings together […]
May 2-4, 2011 Deutsche Bank 36th Annual Health Care Conference
May 2-4, 2011 Hosted by Deutsche Bank Securities InterContinental Boston 510 Atlantic Avenue Boston, MA 02210 tel. +1(617)747-1000 fax. +1(617)217-5190 Senior executives from over 150 […]
Painless Injections Make Child Vaccine Delivery As Easy As Pie
AtriCure founder, Michael Hooven‘s next project could change the way children are injected with vaccines. The days of the big, scary needles are coming to an end.
April 13 – 14, 2011 4th Annual FDA/MTLI Medical Device and IVD Statistics Workshop
This annual conference brings together leading authorities from FDA, industry, and academia to address statistical issues related to medical technology clinical studies
LifeCare Displays Glucose Level Data In An Ordinary Wristwatch For Diabetic Patients
LifeCare is a medical devices company that has developed a technological platform for continuous glucose monitoring in diabetic patients. The company’s technology is based on […]
LeukoDx Can Provide Actionable Diagnostics Within Minutes
LeukoDx is a medical devices company that has developed a diagnostic platform that provides actionable diagnostics, or critical diagnostic information within minutes at the point of care.
MTM Laboratories Can Detect The Earliest Stages of Cervical Cancer
MTM Laboratories has developed a proprietary technological platform that has identified a novel biomarker that serves for the early detection of cervical cancer.